AI supercharges drug discoveries, potentially changing medicine
Biotech company Recursion used AI and supercomputers to predict an unprecedented number of chemical reactions that could lead to effective drugs.
Stay updated with breaking news from Utah Based Recursion. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biotech company Recursion used AI and supercomputers to predict an unprecedented number of chemical reactions that could lead to effective drugs.
Nvidia (NASDAQ:NVDA) price spring up Wednesday, on word the chipmaker will invest $50 million in Recursion Pharmaceuticals to speed up the development of the biotech firm’s artificial intelligence models for drug discovery, the companies said Wednesday. ...
Nvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners, including Roche and Bayer.
Nvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners, including Roche and Bayer.
Nvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners, including Roche and Bayer.